Jun Imai

Title: Innovations by Jun Imai

Introduction

Jun Imai is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceuticals, holding a total of five patents. His work focuses on developing innovative drug formulations that address various medical conditions.

Latest Patents

One of Jun Imai's latest patents is a transdermal absorptive drug formulation. This formulation contains 3-isobutyryl-2-isopropylpyrazolo [1,5-a]pyridine as the active ingredient, which is effective for treating bronchial asthma and cerebrovascular disorders. The formulation is designed to provide excellent sustained release and long-acting characteristics while substantially reducing side effects such as nausea and vomiting. Another significant patent is for a therapeutic pharmaceutical composition that includes 3,4,5-trimethoxy-N-3-piperidylbenzamide, commonly known as troxipide. This composition is intended for the treatment of gastritis and can be administered orally in various forms, including tablets, capsules, granules, and fine granules.

Career Highlights

Jun Imai is associated with Kyorin Seiyaku Kabushiki Kaisha, a company known for its focus on innovative pharmaceutical solutions. His work at Kyorin has allowed him to contribute to the development of effective treatments that improve patient outcomes.

Collaborations

Jun Imai has collaborated with several professionals in his field, including Shinji Kamijo and Tsutomu Irikura. These collaborations have played a crucial role in advancing his research and patent developments.

Conclusion

Jun Imai's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective drug formulations. His patents reflect a deep understanding of medical needs and a dedication to reducing side effects in treatments.